Studies on the venoconstrictor effect of ergot compounds in man.
D000818:Animals; D002415:Cats; D004285:Dogs; D004876:Ergot Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D009130:Muscle, Smooth / Q000187:drug effects; D011941:Receptors, Adrenergic / Q000187:drug effects; D013268:Stimulation, Chemical; D014662:Vasoconstrictor Agents; D014680:Veins / Q000187:drug effects*
D004876:Ergot Alkaloids; D011941:Receptors, Adrenergic; D014662:Vasoconstrictor Agents